Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos

Study identification

• EU PAS number:
  EUPAS1000001151
• Study ID:
  1000001151
• Official title and acronym:
  Real-World Effectiveness of RSV Vaccines Among Adults Using Target Trial Emulation in Epic Cosmos
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  No information provided.
• Study status:
  Ongoing

Research institutions and networks

Institutions

Pfizer

Study timelines

Date when funding contract was signed

Planned:12/12/2025

Actual:12/12/2025

Study start date

Planned:22/06/2026

Actual:22/06/2026

Date of final study report

Planned:31/01/2028

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

No information provided.

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable

Other study registration identification numbers and links

C3671094 (Internal sponsor identifier)